Together, these results may explain the previous observations of increased expression of IL-17 in patients with inflammatory bowel disease such as ulcerative colitis, which promotes the recruitment of inflammatory cells into the intestinal mucosa through an increase in chemoattractants and the expression of adhesion molecules [4], [42], [43], [44]. The gene discussed is IL17A; the disease is inflammatory bowel disease.